Annual Report

Overview

The report describes a year of strong regulatory and commercial progress for the company, including US FDA Fast Track Designation, completion of the paediatric IsoCOMFORT study and Sedaconda approval in the United Kingdom. The company reported 2023 sales of SEK 154 million, up 16 percent at constant exchange rates, while its share began trading on Nasdaq Stockholm Main Market. The sustainability section describes the Code of Conduct, UN Global Compact support, employee initiatives and work to reduce the environmental footprint.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 15 April 2024
Language: English
Pages
File size
Restatement: Disclosed

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services